Navigation Links
Nearly 50 percent of M.D.s believe diversion of ADHD stimulant medications among teens is a problem

VANCOUVER, BC Two recent studies by investigators at the Cohen Children's Medical Center of New York examined physicians' perceptions and knowledge of diversion of stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD) as well as practices physicians use to prevent diversion among their patients prescribed these medications.

The results showed that while almost half of all physicians surveyed believe diversion is common among teens with ADHD, the majority never received training on the topic. Furthermore, about one-third of physicians rarely counsel teens about the health and legal consequences of diverting stimulating medication and don't feel qualified to do so.

"Diversion of stimulation medications for ADHD by high school and college students is widespread as those with ADHD are often sharing pills with their peers, who don't have the condition, to try to improve their academic performance," said Andrew Adesman, MD, senior investigator and chief of developmental behavioral pediatrics at Cohen Children's Medical Center of New York. "Many pediatric colleagues don't feel adequate in counseling their ADHD patients about diverting stimulant medications or are unfamiliar with some of the legal and health consequences of non-ADHD patients taking an unprescribed controlled substance." The survey analyzed responses from 815 physicians who specialize in ADHD child neurologists, child psychiatrists and developmental pediatricians. In the past 12 months, 59 percent of physicians suspected some of their teen ADHD patients were diverting their medications and 54 percent believed some patients were exaggerating symptoms to obtain stimulation medications to divert. When evaluating teens for an initial diagnosis of ADHD, 66 percent of doctors suspected that some patients were trying to obtain stimulant medication to improve academic performance. Surveyed doctors also believed patients wanted the medication to either lose weight (40 percent), get high (38 percent) or divert their stimulant medication to others (39 percent).

The study also showed that the majority of physicians received no training on prevention of prescription drug diversion in medical school (73 percent), residency (57 percent) or fellowship (51 percent).

When physicians were asked if there is a difference in the legal consequence of selling vs. giving away stimulant medication, 19 percent chose the wrong answer and 36 percent were unsure.

Dr. Adesman said that "in the eyes of the law, there is no difference between someone giving away a pill or selling one; they are both prosecuted as unlawful distribution of a controlled substance."

As far as health risks, he also noted that, "A patient taking an ADHD medication has been titrated up to a certain dose over time. If someone else takes another person's dose it can be risky because there is no health history and medication naivet can lead to potential risks, especially if there is an underlying heart condition.

"While many prevention strategies can be used to prevent diversion of stimulant medication informational brochures, a medication contract, pill counts, limiting pill quantities, counseling and other methods, our research showed that while doctors are encouraged to use many of these strategies, most MDs don't believe the strategies to be effective," Dr. Adesman said. "It is important that physicians treating patients with ADHD are continually educated about stimulant diversion problems and become active in mitigating this from happening."


Contact: Betty Olt
North Shore-Long Island Jewish (LIJ) Health System

Related medicine news :

1. Pre-diabetes and diabetes nearly double over the past 2 decades
2. Nearly 97 percent of health professionals wash their hands when patients are asked to watch: Study
3. Food allergy nearly doubles among black children
4. SpeedRFP Use Grows 70 Percent in 2013, With Nearly 50,000 Unique Event RFPs Submitted During the Year
5. Secures Nearly $1,000,000 in Series A Round to Power Healthcare Communication
6. Are you listening? Kids ear infections cost health care system nearly $3 billion a year
7. Nearly 900 Cases Now Pending in Federal Biomet Hip Lawsuit Litigation; Federal Judge Sets Deadlines for Bellwether Trial Selection, Bernstein Liebhard LLP Reports
8. Stryker Hip Injury Claims Number Nearly 400 in Federal Court, Rottenstein Law Group LLP Reports
9. DePuy Pinnacle Lawsuit Claims Mount, as Bernstein Liebhard LLP Notes Nearly 6,000 Filings in Federal Pinnacle Hip Litigation
10. Wright Hip Lawsuits News: Nearly 80 Lawsuits Consolidated in Federal Court, Rottenstein Law Group LLP Reports
11. Releases "Self-Pay" Prices for Common Procedures at Nearly 400 California Hospitals
Post Your Comments:
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast ... found on mammography, according to a study published online in the journal Radiology. ... on mammography may necessitate a change in treatment. , Breast MRI is the ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: